Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
13 Jun 2025
EAACI 2025: Chronic Urticaria Linked to Higher Rates of Comorbid Diseases
Conducted across 19 countries, this large-scale observational study gathered data from 1,392 patients with CSU and 1,374 healthy controls.
13 Jun 2025
Onradivir Rivals Oseltamivir in Treating Influenza A
A large Phase III trial has found that onradivir, a novel PB2 polymerase inhibitor, significantly shortens recovery time in adults with uncomplicated influenza A.
13 Jun 2025
Ultrasound Enhances Diagnosis of Forearm Lacerations in Trauma Care
High-resolution ultrasound improves diagnosis of tendon and nerve injuries in forearm lacerations, supporting better trauma care outcomes.
13 Jun 2025
Breaking Barriers in Lung Cancer: Leveraging AI and Big Data in Clinical Care
In this second episode of our lung cancer podcast series, Jonathan Sackier is joined by David Baldwin, a leading expert in lung cancer screening, epidemiology, and policy.
13 Jun 2025
Dapagliflozin Emerges as Potential MASH Therapy in Landmark Study
Dapagliflozin shows promise for treating MASH, improving liver outcomes without worsening fibrosis in a major trial.
13 Jun 2025
Showcasing Becker muscular dystrophy
Podcast series on Becker Muscular Dystrophy (BMD), exploring diagnosis, disease progression, treatment and…
12 Jun 2025
Tackling Silent Liver Disease: A Global Health Priority
A 2023 global call to action by over 300 experts highlighted the need for clear, cross-specialty care pathways to support earlier identification and referral of people at risk.
UK clinical trial diversity needs work, finds ABPI
New Ipsos data shows that while 58% of UK adults are willing to join clinical trials, this drops to 41% among ethnic minority adults.
12 Jun 2025
EULAR 2025: MONITOR-PsA Study Confirms Feasibility of Treat-to-Target in Routine Practice
A new analysis from the MONITOR-PsA study, presented at EULAR 2025, demonstrates that a pragmatic treat-to-target (T2T) approach in psoriatic arthritis leads to promising clinical outcomes over 48 weeks.
12 Jun 2025
Onc Now: Episode 19: Key Insights from SGO 2025
Bradley Monk, Medical Director of Late-Phase Clinical Research at Florida Cancer Specialists, shares key understandings from the Society of Gynecologic Oncology (SGO) 2025, alongside a fascinating deep dive into drug approval and access.
←
1
2
3
…
119
120
121
122
123
124
125
…
1,262
1,263
1,264
→
We’ve noticed you’re accessing
from
North/South America.
View
View